We confirmed substantial SSTR2 expression in both HCC cell lines and patient samples, demonstrating that radiolabeled compounds such as 67Ga-DOTATATE and 177Lu-DOTATATE—widely used for neuroendocrine tumors—can also specifically target HCC. This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.